Shruti Bhat PhD, MBA, Lean Six Sigma Black Belt
  • Home
  • About Shruti
  • Consulting
  • Workshops
  • Patents
  • Articles
    • Case Studies
    • Innovation Portfolio Development & Patents
    • Drugs-in-the- making
    • Culture Change & Business Transformation
    • Operational Excellence, Quality & Continuous Improvement
  • Books
  • Digital
  • Blog
  • Videos
  • Contact

Life cycle management and Intellectual property management for pharmaceutical generics.

5/18/2011

0 Comments

 
Brand Teams Protect Their Products With an Average of Five Distinct Strategies, According to Cutting Edge Information Successful pharmaceutical and biotechnology product teams are finding that spreading their bets across multiple strategies produces the best results, according to a new report on patent defense. Research results show that a willingness to invest in widely varying strategies has driven the success of some companies in defending their drugs throughout the brand life cycle.

Large Companies Investing More in Brand Defense-

According to the new study, Countering Generic and Biosimilar Threats: Near-Term and Long-Term Strategies, Top 10 pharmaceutical companies attempt an average of 5.4 counter-generics tactics per brand. The next 15 top drug companies average five specific counter-generics approaches per brand, and the remainder of the industry's Top 50 companies attempt 4.2 strategies. Smaller drug companies outside the Top 50 employ fewer strategies per product on average.

The ability to deploy more brand-preservation strategies helps larger companies fend off generic competitors. "Companies need to plan and allow time for a diverse range of counter-generics strategies," said Jason Richardson, president of Cutting Edge Information.

"Brand leaders need to make these considerations while there is still sufficient time before market exclusivity ends to be thoughtful," he said.

Defense Strategies Must Include Short and Long Views-

Efforts to extend patent protection do not always deliver hoped-for results, as extensions rely on trial success and regulatory approval. Shorter-term strategies such as pricing, counter-promotions and patent litigation may require less time and money, but they only delay revenue erosion for a relatively brief period of time.

"The direction of a successful lifecycle management strategy is often driven by its market and competitive landscape," said Ryan McGuire, author of the study.

"Small companies don't often have the blockbusters in their portfolio that generic companies most frequently target. Therefore, only a few tactics may suit a small company's brand team as it approaches patent expiration."
​​Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
#ProductLifeCycleManagement
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement

    New Book Released!

    top ten strategic decision-making tools for operational excellence

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    5S
    Agile
    Artificial Intelligence
    Automation
    Balanced Score Card
    Biotechnology
    Books
    Business Turnaround
    Case Studies
    Change Management
    Chemical Industry
    CMMI
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Food Industry
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    Nanotechnology
    Operations
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    Robotics
    Scrum
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    TQM
    Videos
    Voice Of Customer
    Workshops

    Shruti's books...

    Picture
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    Picture
    how to overcome challenges of creating effective teams
    how to lead a successful business transformation

    ​Micro-Learning
    ​Partner

    Picture

    Publishing Partner

    fast read books, business management books, health and wellness books, spiritual guidance books, best online book store

    Wellness
    ​Partner

    Picture
© Copyright 1992- 2022 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media